Most liver diseases are diagnosed when it’s already too late. This episode explores the pros and cons of early screening, the gaps in current strategies, and how projects like LIVERAiM are aiming to change the game.

Moderator: Ahmed Elsharkawy

Faculty: Pere Ginès, Ian Rowe, Maja Thiele

All EASL Studio Podcasts are available on EASL Campus.

Click here to see all EASL Video Podcasts on Apple Podcasts.

This EASL Studio episode cuts through the noise to explore alcohol’s true impact on health and society, spotlighting patient stories, public misconceptions, and bold policy solutions from across Europe.

Moderator: David Barret (Internal Communications and Multimedia Manager, WHO Regional Office for Europe)

Faculty: Carina Ferreira-Borges (Regional Advisor for Alcohol, Illicit drugs and Prison health, WHO Regional Office for Europe), Aleksander Krag (EASL Secretary General), Hazel Martin (BBC Journalist and Liver Patient), Margarida Santos (General Practitioner Portugal), Riina Sikkut (Member of Estonian Parliament, former Minister of Health of Estonia)

All EASL Studio Podcasts are available on EASL Campus.

Click here to see all EASL Video Podcasts on Apple Podcasts.

What happens when hepatologists and interventional radiologists join forces? This episode discusses the power of collaboration – shared guidelines, joint training, and multidisciplinary care – to improve outcomes in complex liver disease.

Moderator: Sven Francque

Faculty: Irene Bargellini, Virginia Hernández-Gea, Max Seidensticker

All EASL Studio Podcasts are available on EASL Campus.

Click here to see all EASL Video Podcasts on Apple Podcasts.

In this fifth edition of the EASL DeepDive, join Christophe Bureau, Virginia Hernandez-Gea, Marika Rudler, and Manhal Izzy to gain expert insight into the selection, management, and outcomes of patients undergoing Transjugular Intrahepatic Portosystemic Shunt (TIPS) procedures.

This EASL DeepDive webinar is supported by W. L. Gore & Associates. W. L. Gore & Associates has had no input into the content of this EASL DeepDive.

Learning objectives

• Understand the criteria for selecting appropriate patients for Transjugular Intrahepatic Portosystemic Shunt (TIPS) procedures
• Learn to differentiate between high-risk and low-risk patients based on clinical indicators and patient history
• Explore the impact of cardiopulmonary conditions on the outcomes of TIPS procedures, and how/when to monitor for new-onset heart failure post TIPS
• Learn from Marika Rudler about the strategies for preventing and managing post-TIPS hepatic encephalopathy (HE)
• Discuss the latest research and treatments available for managing EH in TIPS patients

All EASL DeepDive are available on EASL Campus.

This EASL Studio episode discusses cutting-edge approaches for managing bleeding varices. Explore the evolution of endoscopic therapies, the role of interventional radiology, and decision-making for high-risk gastric varices. Gain insights into EUS-guided portal pressure assessment and its impact on tailoring treatment strategies.

Moderator: Debbie Shawcross

Faculty: Wim Laleman, David Patch

Related episode

• S6E14: Endohepatology: The endoscopic liver gold rush

All EASL Studio Podcasts are available on EASL Campus.

Click here to see all EASL Video Podcasts on Apple Podcasts.

In this EASL DeepDive held on 06 November 2024, Alice Turner, Pavel Strnad, and Nicola Brunetti discuss and explore the changing insights in the management of Alpha-1 Antitrypsin Deficiency.

Learning objectives:

1. Learn more about the role of heterozygosity of alpha-1 as a risk factor for chronic liver disease, especially in the context of other causes such as MASLD or alcohol
2. Get a better understanding of the extrahepatic manifestations and the need for a multi-disciplinary approach
3. Learn more about screening: who to screen and how
4. Discover the general unmet needs related to AAT, with an emphasis on awareness and timely diagnosis

This EASL DeepDive webinar is supported by Takeda Pharmaceuticals. Takeda Pharmaceuticals has had no input into the content of this EASL DeepDive.

Click here to see all EASL Video Podcasts on Apple Podcasts.

In this EASL DeepDive held on 03 July 2024, Palak Trivedi, Emma Culver, Andreas Kremer and Jessica Dyson explain the risk assessment in people with PBC as well as the mechanistic and treatment of fatigue and pruritus.

Learning objectives

• Discover the latest mechanistic insights relating to the occurrence of PBC symptoms
• Learn more about the holistic management of PBC symptoms, with a particular emphasis on fatigue and pruritus
• Learn more about the current treatment options, their efficacy and limitations
• Get a detailed understanding of the drugs in the pipeline for the near future

This EASL DeepDive webinar is supported by GSK and IPSEN. GSK and IPSEN have had no input into the content of this EASL DeepDive.

Click here to see all EASL Video Podcasts on Apple Podcasts.

In this EASL DeepDive held on 30 October 2024, Henning Grønbæk, Cyrielle Caussy, Mazen Noureddin and Frank Tacke provide an understanding of the role of glucagon and glucagon-receptors in physiology and in MASH patients. Additionally, they review key clinical trials and evaluate the integration of GLP-1 receptor agonists into current EASL-EASD-EASO clinical guidelines for practical patient management.

Learning objectives:

1. Understand the role of glucagon and glucagon-receptor in normal physiology and disease.
2. Understand the rationale of a combined dual GLP-1/GCG RA and its potential benefit compared to a GLP-1RA alone and thus gain insights into the mechanisms through which GLP-1 receptor agonists and GLP-1/GCG might affect liver pathology and metabolic regulation.
3. Discuss and review key clinical trials and ongoing development programs.
4. Evaluate how GLP-1RA can be integrated into current EASL-EASD-EASO CPGs, with a focus on practical applications and patient management strategies, giving potential guidance for future applications.

This EASL DeepDive webinar is supported by Boehringer Ingelheim. Boehringer Ingelheim has had no input into the content of this EASL DeepDive.

Click here to see all EASL Video Podcasts on Apple Podcasts.

In this EASL DeepDive held on 25 February 2025,  Ana Lleo, Adriaan van der Meer, Gideon Hirschfield, and Bettina Hansen explore the future of primary biliary cholangitis (PBC) treatment. Discover the emerging therapies, current challenges and personalised approaches that are shaping the management of PBC.

Learning objectives

• Learn more about the molecular mechanisms underlying the disease and the potential targets for drug therapy
• Get a good understanding of the efficacy of the current drugs and the potential added value of the upcoming second line treatments for PBC and where to position these new treatments in the treatment landscape
• Learn more about the evolving concepts regarding the endpoints in clinical trials for PBC
• Get insights in the risk assessment of people living with PBC and criteria for second line therapy 

This EASL DeepDive webinar is supported by Gilead. Gilead has had no input into the content of this EASL DeepDive.

Click here to see all EASL Video Podcasts on Apple Podcasts.

This episode celebrates 40 years of the Journal of Hepatology, EASL’s flagship journal.

Tune in to discover how far we’ve come—and what’s next for the journal.

Moderator: Thomas Berg 

Faculty: Paolo Angeli, Annalisa Berzigotti, Rajiv Jalan, Vlad Ratziu, Frank Tacke and Jessica Zucman-Rossi

All EASL Studio Podcasts are available on EASL Campus.

Click here to see all EASL Video Podcasts on Apple Podcasts.